Understanding Current Frontline Treatment: COG and SIOPEN
This session provides an in-depth look at current frontline treatment strategies for high risk neuroblastoma, focusing on how therapy is delivered in the United States through COG (Children’s Oncology Group) and in Europe through SIOPEN (International Society of Paediatric Oncology Europe Neuroblastoma). The discussion highlights key elements of the HRBL2 and ANBL2131 protocols and ends with a question and answer session.
▶︎
The MINT Study: Addressing Unmet Need in High‑Risk Neuroblastoma
▶︎
What is neuroblastoma and post-maintenance therapies
▶︎
BEACON2: Expanding Treatment Options for Relapsed Neuroblastoma
▶︎
Finding Trusted Information: Navigating the Neuroblastoma Journey
▶︎
Free Event: Power BI Beginner to Pro 2026 Edition - Full Hands-On Tutorial
▶︎
5 Things That Surprise People Most About Hip Replacement
▶︎
Learning how to learn | Barbara Oakley | TEDxOaklandUniversity
▶︎
IHSCM Showcase: 'Digital Pathway Redesign to Enable Early Screening' - Dr Ramai Santhirapala
▶︎
Politics Chat, June 23, 2026
▶︎
How to increase your vocabulary: Live English Class
▶︎
I Lived Another Life In a Coma | It Happened to Me
▶︎
Bin Workers Find Bloated Dog in Woods — Vet Rushes to Save Her! | Rescue Vet with Dr Scott Miller
▶︎
Automatic packaging machines and packaging systems for Kits
▶︎
Why EDS is more than "just loose joints" | (MIS)Treated
▶︎
How to Fall in Love with Someone | Yale Conversations with David Brooks | Yale University
▶︎
Everything Hollywood Gets Wrong About Firefighters | Fire Department Chronicles
▶︎
Health Update: A New Perspective On Life
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Doctor Explains Why They're Terrified to Speak Out
▶︎